Pulmonary arterial hypertension in France: results from a national registry.
Explore this paper's citation graph
Summary
It is shown that PAH is detected late in the course of the disease, with a majority of patients displaying severe functional and hemodynamic compromise, and this contemporary registry highlights current practice.
- Type
- article
- Published
- 2006-05-01
- Cited by
- 1,838
- References
- 28
- OpenAlex
- https://openalex.org/W2141262339
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:15339420
Keywords
Medicine, Vascular resistance, Pulmonary hypertension, Cardiac index, Cohort
References
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
- Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?
- [Socioeconomic determinism of obesity in the Seine-Saint-Denis area].
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
- Primary pulmonary hypertension.
- Reference equations for the six-minute walk in healthy adults.
- Diagnosis and differential assessment of pulmonary arterial hypertension.
- Clinical classification of pulmonary hypertension.
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
- Pulmonary–Hepatic vascular Disorders (PHD)
- Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
- Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
- Primary pulmonary hypertension associated with the use of fenfluramine derivatives.
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients.
- Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival.
- Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
- Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension.
- Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.
- PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY
- Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
Cited by
- Mise au point sur les traitements de l’hypertension artérielle pulmonaire de l’enfant
- ALK1 et BMP9 dans le remodelage vasculaire de la génétique humaine aux modèles murins
- Echocardiographic assessment of the impact of exercise training at different time points of the development of experimental pulmonary arterail hypertension
- Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension
- Development of strategies for vascular damage repair in Pulmonary Arterial Hypertension
- Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
- Phosphodiesterase inhibitors for pulmonary hypertension.
- Naming and understanding rare diseases: International Classification of Diseases coding and the epidemiologic designations of idiopathic pulmonary arterial hypertension.
- Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
- Clinical features of paediatric pulmonary hypertension: a registry study
- The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future
- Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics
- Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension
- The Estrogen Metabolite 16αOHE Exacerbates BMPR2-Associated PAH Through miR-29-Mediated Modulation of Cellular Metabolism
- Update on pulmonary arterial hypertension pharmacotherapy
- Mexican registry of pulmonary hypertension: REMEHIP.
- Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes.
- Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
- Portopulmonary hypertension: A focused review for the internist
- Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience.
Related papers
- Effect of Feixinping on ET and NOSmRNA Expression in Pulmonary Artery in Rats with Pulmonary Hypertension in Pulmonary Heart Disease
- [Determination of pulmonary vascular resistance by improved right heart catheter in rat].
- Heparin in experimental hyperdynamic sepsis
- Computed tomography measurement of pulmonary artery size in interstitial lung disease to evaluate pulmonary hypertension
- [Nitroglycerin infusion in patients with or without cardiac failure. Demonstration by multifactorial analysis (analysis of correspondences) of three types of hemodynamic response dependent upon the initial state (author's transl)].
- [Preliminary criteria for the diagnosis of pulmonary hypertension in mixed connective tissue disease].
- Left Pulmonary Artery Ligation and Chronic Pulmonary Artery Banding Model for Inducing Right Ventricular - Pulmonary Hypertension in Sheep
- Haemodynamic effects of ionophore (X-537A) in cats.
- Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates
- Inaccuracy of the FloTrac/Vigileo™ system in patients with low cardiac index.